GAM Holding’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-8,398
| Closed | -$696K | – | 231 |
|
|
2022
Q2 | $696K | Hold |
8,398
| – | – | 0.05% | 197 |
|
|
2022
Q1 | $648K | Sell |
8,398
-2,164
| -20% | -$181K | 0.03% | 216 |
|
|
2021
Q4 | $933K | Hold |
10,562
| – | – | 0.04% | 201 |
|
|
2021
Q3 | $816K | Buy |
10,562
+1
| +0% | +$79 | 0.04% | 209 |
|
|
2021
Q2 | $881K | Sell |
10,561
-12,241
| -54% | -$970K | 0.04% | 234 |
|
|
2021
Q1 | $1.72M | Buy |
+22,802
| New | +$1.86M | 0.08% | 208 |
|
|
2020
Q4 | – | Sell |
-22,811
| Closed | -$1.74M | – | 280 |
|
|
2020
Q3 | $1.74M | Sell |
22,811
-6,689
| -23% | -$677K | 0.1% | 211 |
|
|
2020
Q2 | $3.64M | Sell |
29,500
-9,713
| -25% | -$965K | 0.23% | 135 |
|
|
2020
Q1 | $3.31M | Sell |
39,213
-3,194
| -8% | -$275K | 0.23% | 124 |
|
|
2019
Q4 | $3.59M | Buy |
42,407
+7
| +0% | +$529 | 0.17% | 157 |
|
|
2019
Q3 | $2.86M | Hold |
42,400
| – | – | 0.13% | 187 |
|
|
2019
Q2 | $3.63M | Hold |
42,400
| – | – | 0.14% | 163 |
|
|
2019
Q1 | $3.77M | Sell |
42,400
-1,202
| -3% | -$111K | 0.16% | 155 |
|
|
2018
Q4 | $3.71M | Sell |
43,602
-5,100
| -10% | -$485K | 0.19% | 134 |
|
|
2018
Q3 | $4.72M | Buy |
48,702
+27,452
| +129% | +$2.74M | 0.17% | 146 |
|
|
2018
Q2 | $2M | Buy |
21,250
+19,300
| +990% | +$1.69M | 0.07% | 287 |
|
|
2018
Q1 | $158K | Buy |
+1,950
| New | +$167K | 0.01% | 800 |
|
|
2017
Q3 | – | Sell |
-10,495
| Closed | -$953K | – | 591 |
|
|
2017
Q2 | $953K | Hold |
10,495
| – | – | 0.01% | 652 |
|
|
2017
Q1 | $921K | Sell |
10,495
-7,456
| -42% | -$663K | 0.01% | 668 |
|
|
2016
Q4 | $1.49M | Buy |
17,951
+8,411
| +88% | +$723K | 0.03% | 547 |
|
|
2016
Q3 | $883K | Buy |
9,540
+4,650
| +95% | +$438K | 0.02% | 633 |
|
|
2016
Q2 | $380K | Sell |
4,890
-28,265
| -85% | -$2.4M | 0.01% | 791 |
|
|
2016
Q1 | $2.73M | Sell |
33,155
-56,174
| -63% | -$4.57M | 0.05% | 391 |
|
|
2015
Q4 | $9.36M | Buy |
89,329
+33,651
| +60% | +$3.51M | 0.15% | 174 |
|
|
2015
Q3 | $5.86M | Buy |
55,678
+32,814
| +144% | +$4.38M | 0.1% | 223 |
|
|
2015
Q2 | $3.13M | Sell |
22,864
-1,736
| -7% | -$215K | 0.05% | 399 |
|
|
2015
Q1 | $3.07M | Sell |
24,600
-68,600
| -74% | -$7.27M | 0.05% | 401 |
|
|
2014
Q4 | $8.43M | Sell |
93,200
-20,860
| -18% | -$1.73M | 0.13% | 198 |
|
|
2014
Q3 | $8.23M | Buy |
114,060
+24,000
| +27% | +$1.58M | 0.12% | 209 |
|
|
2014
Q2 | $5.6M | Buy |
90,060
+14,982
| +20% | +$905K | 0.09% | 259 |
|
|
2014
Q1 | $5.12M | Hold |
75,078
| – | – | 0.08% | 276 |
|
|
2013
Q4 | $5.28M | Buy |
75,078
+1,142
| +2% | +$77.6K | 0.09% | 248 |
|
|
2013
Q3 | $5.34M | Sell |
73,936
-4,600
| -6% | -$306K | 0.1% | 238 |
|
|
2013
Q2 | $4.38M | Buy |
+78,536
| New | +$4.89M | 0.1% | 259 |
|
Other funds holding BMRN
BBA
GAM Holding's BMRN Position: Q3 2022 in Review
GAM Holding sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2022, closing a stake of 8,398 shares — an estimated $696K sold.
GAM Holding first reported a position in BMRN in Q2 2013 and held it in 34 quarters. The position peaked at $9.36M in Q4 2015. 551 funds tracked by Wall St. Rank hold BMRN as of Q3 2022.
- GAM Holding reported no remaining BioMarin Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
- GAM Holding sold 8,398 BioMarin Pharmaceuticals shares in Q3 2022, an estimated $696K.
- GAM Holding first reported a position in BioMarin Pharmaceuticals in Q2 2013 and held it in 34 quarters.
- GAM Holding's BioMarin Pharmaceuticals position peaked at $9.36M in Q4 2015.
- 551 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2022.
Based on GAM Holding's 13F filing for Q3 2022, filed 19 Oct 2022.